Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects:
|Acute Porphyrias
|Variegate Porphyria
|Acute Intermittent Porphyria (AIP)
|Porphyria Cutanea Tarda (PCT)
|Porphyria Testing
π©Έ Acute porphyrias are hereditary disorders of haem biosynthesis (prevalence ~1 in 75,000). They can cause severe, potentially life-threatening neurovisceral attacks.
β οΈ The BNF advises: if no safe alternative exists, essential drug treatment should not be withheld even in patients with acute porphyria.
π Treatment: In the UK, haem arginate (hemin) is given IV during acute crises (via NAPS at Cardiff or Kingβs College London). IV dextrose is also used to suppress haem synthesis.
π About
π National UK Links
𧬠Types of Acute Porphyria
Type
Details
π©Ί Acute Intermittent Porphyria (AIP)
Most common. Deficiency of porphobilinogen deaminase. Presents with abdominal pain, neuropsychiatric features, and autonomic dysfunction.
βοΈ Hereditary Coproporphyria (HCP)
Deficiency of coproporphyrinogen oxidase. Similar to AIP but can cause photosensitivity.
π Variegate Porphyria (VP)
Deficiency of protoporphyrinogen oxidase. Acute neurovisceral attacks + blistering photosensitivity.
π§ͺ ALAD Deficiency Porphyria (ADP)
Rare. Deficiency of delta-ALA dehydratase. Mainly neurological symptoms.
β οΈ Precipitants
π« Drugs to Avoid (check full list in BNF/UKPMIS)
π©Ί Clinical Features
π Investigations
Test Use
π§ͺ Urine PBG Most important initial test β elevated in AIP attacks.
π§ͺ Urine ALA Also elevated during acute attacks.
π‘ Plasma fluorescence Diagnostic for VP & HCP under UV light.
π© Stool porphyrins Helps confirm VP/HCP.
𧬠Genetic testing Confirms mutation and porphyria subtype.
π§ͺ Enzyme activity Useful in AIP (PBG deaminase deficiency).
π©Ί LFTs Assess hepatic involvement and monitor long-term risks (HCC).
π οΈ Management (UK Practice)
π‘οΈ Prevention
π References